--- title: "Nio, XPeng End 2025 with Higher December Deliveries, Li Auto Reports a 24% Decline" type: "News" locale: "en" url: "https://longbridge.com/en/news/271275497.md" description: "Chinese EV makers Nio and XPeng reported growth in December 2025 deliveries, with Nio delivering 48,135 vehicles (54.6% YoY growth) and XPeng delivering 37,508 units (2% YoY growth). Li Auto faced a 24% decline in deliveries. Nio's strong performance was driven by demand for its ES8 SUV, while XPeng's 2025 deliveries surged 126% to 429,445 units. Wall Street rates XPEV as a Moderate Buy with a price target of $29.67, while Nio holds a Hold rating with a target of $5.90." datetime: "2026-01-01T13:05:17.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/271275497.md) - [en](https://longbridge.com/en/news/271275497.md) - [zh-HK](https://longbridge.com/zh-HK/news/271275497.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/271275497.md) | [繁體中文](https://longbridge.com/zh-HK/news/271275497.md) # Nio, XPeng End 2025 with Higher December Deliveries, Li Auto Reports a 24% Decline Chinese electric vehicle (EV) makers Nio (NIO) and XPeng (XPEV) reported year-over-year growth in their December 2025 deliveries, while Li Auto (LI) continued to struggle and reported a 24% decline in its deliveries. Chinese EV makers are under pressure amid intense price wars and market saturation. ### Claim 70% Off TipRanks This Holiday Season - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential ## **Nio and XPeng Report Growth in December Deliveries** Nio delivered 48,135 vehicles in December 2025, reflecting a 54.6% year-over-year growth and a 33% sequential increase. The strong growth in Nio's December deliveries was driven by the demand for its new ES8 premium SUV. Nio highlighted that the ES8 has crossed 40,000 cumulative deliveries, marking the fastest delivery record among BEVs (battery electric vehicles) priced above RMB 400,000 in China. Overall, Nio's Q4 2025 deliveries grew about 72% year-over-year, while full-year 2025 deliveries surged 47% to 326,028 EVs. Recently, NIO stock jumped after the company's CEO stated that Q4 vehicle sales are expected to exceed 30 billion yuan. Meanwhile, XPeng reported a modest 2% year-over-year and sequential increase in December deliveries to 37,508 units. The company's Q4 2025 deliveries increased 27% year-over-year to 116,249 vehicles. While XPeng's Q4 deliveries fell short of its guidance range of 125,000 to 132,000 EVs, the Chinese EV maker's 2025 deliveries jumped about 126% to 429,445 units. XPeng expects its extended-range electric vehicle (EREV) models and continued international expansion to drive its 2026 sales. ## **Here's Wall Street's Take on NIO and XPEV Stocks** Currently, Wall Street has a Moderate Buy consensus rating on XPEV stock, with a price target of $29.67, indicating 46.3% upside potential. Meanwhile, Nio has a Hold consensus rating, with the average price target of $5.90, implying 16% upside potential. ### Related Stocks - [XPeng Inc. (XPEV.US)](https://longbridge.com/en/quote/XPEV.US.md) - [XPENG-W (09868.HK)](https://longbridge.com/en/quote/09868.HK.md) - [NIO-SW (09866.HK)](https://longbridge.com/en/quote/09866.HK.md) - [NIO Inc (NIO.SG)](https://longbridge.com/en/quote/NIO.SG.md) - [NIO Inc (NIO.US)](https://longbridge.com/en/quote/NIO.US.md) ## Related News & Research - [Nio Firefly sets Apr 7 for EV upgrade to sustain sales momentum](https://longbridge.com/en/news/281601076.md) - [Nio ES8 deliveries reach 16,255 in Mar, purchase incentives extended](https://longbridge.com/en/news/281447428.md) - [NIOX streamlines share schemes with block listing update and cancellations](https://longbridge.com/en/news/281553982.md) - [Nio to launch 5-seat ES8 in Jul, eyes Hong Kong entry](https://longbridge.com/en/news/280900900.md) - [Xpeng Mar deliveries rebound sequentially despite year-on-year decline](https://longbridge.com/en/news/281331957.md)